Not affiliated with the Kansas Legislature · an independent reference by Fifty Domes

PlansSign in

Bills › 2025 to 2026 Regular Session › House of Representatives bill

HB 22182025 to 2026
bill

2025 to 2026 Regular Session · House of Representatives bill

HB 2218

Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

In committee Last action February 19, 2026: Stricken from Calendar by Rule 1507

Official bill page and text: kslegislature.gov

Sponsors 1

Prime sponsor
Committee on Health and Human Services

Status

In committee as of February 19, 2026. The 2026 session has adjourned; the 2027 session convenes January 11, 2027.

Referred to: House Health and Human Services (from the official referral record)

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 5

DateChamberAction
February 19, 2026HouseStricken from Calendar by Rule 1507
February 18, 2026HouseCommittee of the Whole - Passed over and retain a place on the calendar
January 28, 2026HouseCommittee Report recommending bill be passed as amended by House Committee on Health and Human Services
February 3, 2025HouseIntroduced
February 3, 2025HouseReferred to House Committee on Health and Human Services

Data: Open States (API v3; public data, attribution appreciated). Official record: kslegislature.gov. Bill pages link to the official text, not copied.

Sources for this page

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Kansas Capitol Guide nor this information, as presented here, is endorsed by the Kansas Legislature.